Dennis Ryan

Lighthouse Capital Partners, Inc. (Lighthouse Capital Partners) is a venture capital firm founded in 1994 by Richard Stubblefield and Gwill York. The firm headquartered in Menlo Park, California.

Foresite Capital Management LLC (Foresite Capital) is a private equity firm founded in 2010 by James Tananbaum. The firm is headquartered in San Francisco.

Part of Kimco Realty Corp., Western Properties Trust is a real estate investment trust. The company is based in Emeryville, CA. The company was founded in 1962. Western Properties Trust was acquired by Pan Pacific Retail Properties, Inc., part of Kimco Realty Corp. from November 02, 2006 on November 14, 2000 for $218.47 million.

FS Development Corp. operates as a blank check company. It is for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Jim Tananbaum in June 2020 and is headquartered in San Francisco, CA.

FS Development Corp. II is a blank check company, which formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more entities. The company was founded by James B. Tananbaum on August 21, 2020 and is headquartered in Larkspur, CA.

Marin Senior Coordinating Council, Inc. provides political data services sourced from multiple social media platforms. The private company is based in San Rafael, CA.

Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA.

Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA.